Site
More than 14 million people are diagnosed with cancer each year and more than 8 million of those die. Indeed, it is evident that a revolution in terms of cancer treatment is gravely needed. One field which potentially holds great promise is immuno-oncology (IO). IO therapies aim to induce or enhance the immune system toaaa
Read moreWe are delighted to announce our speakers line-up for the Innovation Forum 2016 conference. Follow us to keep up to date as we introduce our eminent speakers. “As a CEO of a growing business you need to be able to refer to the expertise of others in order to make strategic decisions. Surrounding yourself with highaaa
Read moreDr Eliot Forster joined Immunocore as Chief Executive Officer in January 2015. He has almost 25 years of experience in the pharmaceutical and biotechnology industry. Dr Forster previously served as Chief Executive Officer of Creabilis since 2010 and prior to that role was Chief Executive Officer of US biotechnology company, Solace Pharmaceuticals Inc. His otheraaa
Read more